Navigation Links
LA BioMed President and CEO will be named president of the American Judicature Society
Date:7/9/2009

LOS ANGELES (July 8, 2009) Carole Wagner Vallianos, Esq., president and CEO of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be inaugurated as the president of the American Judicature Society at its Annual Meeting in Chicago on July 30.

Founded in 1913, the American Judicature Society is an independent, national, nonpartisan organization of judges, lawyers and other members of the public who seek to improve the justice system. The society, which brings a public perspective to justice system issues, has the mission to secure and promote an independent and qualified judiciary and a fair system of justice.

Wagner Vallianos will take over the post from the current president, Gordon L. Doerfer of Boston, MA. Doerfer, who served 25 years on the trial and appellate courts of Massachusetts, is a mediator and arbitrator on the panel of neutrals at JAMS The Resolution Experts.

"I am honored and excited to have this opportunity to serve as president of the American Judicature Society, an organization dedicated to improving and promoting a fair system of justice," said Wagner Vallianos. "I look forward to working with my colleagues in a collaborative and coordinated effort to strengthen the American Judicature Society and the judiciary."

Wagner Vallianos became president and CEO of LA BioMed in September 2008, after serving six years on the institute's board of directors, including two years as the board's chair. She had also served as the board's treasurer and chair of the board's finance committee.

She is a principal in the Law Offices of Carole Wagner Vallianos, a Manhattan Beach firm where she practices civil rights, nonprofit corporation law and estate planning. She was reappointed to the California Judicial Council's Standing Committee on Access and Fairness in the Courts and is a past member of the Jury Improvement Task Force and the Council's Advisory Committees on Race and Ethics Bias in the Courts and Private Judging.

Wagner Vallianos also is a Fellow of the California First Amendment Coalition and a former advisory board member of the Citizen Access Project, University of Florida's Brechner Center for Freedom of Information.

In addition, she is a member of Women Lawyers of Los Angeles, the South Bay Bar Association and the Benjamin Aranda III Inn of Court. She is past president of the League of Women Voters of California, and she was on the Board of Directors of the League of Women Voters of the United States and the Board of Trustees of the League of Women Voters Education Fund.

She has served as an NGO/nonprofit consultant with the U.S. Department of State in Bosnia, Turkey, Cyprus and India. She is a graduate of Coro, a public policy training program, and is a member of Pacific Council on International Policy. Wagner Vallianos received her B.A. from California State University, Fullerton, and her J.D. from Southwestern University School of Law.


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed President and CEO will be named president of the American Judicature Society
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: